Study to Evaluate Loncastuximab Tesirine With Rituximab Versus Immunochemotherapy in Participants With Relapsed or Refractory Diffuse Large B-Cell Lym
A phase 3 trial of Loncastuximab tesirine, Rituximab, Gemcitabine in diffuse large b-cell lymphoma, run by ADC Therapeutics S.A., active and no longer recruiting.
Overview
Study to Evaluate Loncastuximab Tesirine With Rituximab Versus Immunochemotherapy in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma is a phase 3 interventional study registered as NCT04384484 by ADC Therapeutics S.A., with 440 participants enrolled, started 2020-09-16 and due to reach its primary completion in 2026-03-31. Interventions recorded: Loncastuximab Tesirine, Rituximab, Gemcitabine, Oxaliplatin. Conditions listed: Relapsed Diffuse Large B-Cell Lymphoma, Refractory Diffuse Large B-Cell Lymphoma. No results are recorded here; the registry entry is the source.
Similar pages
not linked directly; found by shared links- TrialA Study of Subcutaneously Injected Epcoritamab Plus Oral Lenalidomide Tablets Compared to Intravenously (IV) Infused Rituximab Plus IV Infused Gemcita
Shares CAPOX (capecitabine, oxaliplatin), Rituximab, Gemcitabine, Diffuse large B-cell lymphoma.
- TrialLOTIS-2
Shares Loncastuximab tesirine, Diffuse large B-cell lymphoma.
- TrialA Study of MT-2111 in Patients With Relapsed/Refractory DLBCL
Shares Loncastuximab tesirine, Diffuse large B-cell lymphoma.
- TrialStudy of HMPL-760 Plus R-GemOx Versus Placebo Plus R-GemOx in Relapsed/Refractory DLBCL
Shares Rituximab, Gemcitabine, Diffuse large B-cell lymphoma.
- TrialEfficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients
Shares CAPOX (capecitabine, oxaliplatin), Rituximab, Gemcitabine, Diffuse large B-cell lymphoma.
- TrialA Study of HDM2005 in Combination With Standard of Care in Patients With Diffuse Large B-Cell Lymphoma
Shares CAPOX (capecitabine, oxaliplatin), Gemcitabine, Diffuse large B-cell lymphoma.
- TrialA Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) With or Without Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell Ly
Shares Rituximab, Gemcitabine, Diffuse large B-cell lymphoma.
- CompanyBiogen
Shares Rituximab, Diffuse large B-cell lymphoma.